Literature DB >> 31932274

Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis: A Multicenter Real-Life Experience.

E Nettis1, L Bonzano2, V Patella3, A Detoraki4, P Trerotoli5, C Lombardo6.   

Abstract

Entities:  

Keywords:  Atopic dermatitis; Conjunctivitis; Dupilumab

Mesh：

Substances：

Year:  2020        PMID： 31932274     DOI： 10.18176/jiaci.0481

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  5 in total

1.  Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.

Authors:  Roselie E Achten; Chantal Van Luijk; Lisa Van der Rijst; Daphne Bakker; Lotte Spekhorst; Nicolaas Zuithoff; Marie Schuttelaar; Geertruida Romeijn; Angelique Voorberg; Marijke Kamsteeg; Inge Haeck; Marlies De Graaf; Judith Thijs; Joke De Boer; Marjolein De Bruin-Weller
Journal:  Acta Derm Venereol       Date:  2022-03-11       Impact factor: 3.875

Review 2.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

Review 3.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

4.  Encounters and medication use for ocular surface disorders among patients treated with dupilumab: A cohort study.

Authors:  John S Barbieri; Vatinee Y Bunya; Mina Massaro-Giordano; David J Margolis
Journal:  JAAD Int       Date:  2021-04-29

5.  Clinical Characteristics and Treatment for Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients.

Authors:  Zujaja Tauqeer; Stephanie E Jinno; Caroline W Chung; Mina Massaro-Giordano; Vatinee Y Bunya
Journal:  Clin Ophthalmol       Date:  2022-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.